4 results match your criteria: "West Cancer Clinic[Affiliation]"

Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma.

Gynecol Oncol

June 2023

Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA; Department of Immunology, Duke School of Medicine, Durham, NC 27710, USA; Duke Cancer Institute, Duke School of Medicine, Durham, NC 27710, USA.

Objective: To demonstrate that shared antibody responses in endometriosis and endometriosis-associated ovarian cancer spontaneously antagonize malignant progression and can be leveraged to develop future immunotherapies.

Methods: B cells from cyopreserved clear cell ovarian carcinoma (CCC, n = 2), endometrioid ovarian carcinoma (EC, n = 2), and endometriomas (n = 2) were isolated, activated, and EBV-immortalized. Antibodies were purified from B cell supernatants and used for screening arrays containing most of the human proteome.

View Article and Find Full Text PDF

Loxoscelism: Cutaneous and Hematologic Manifestations.

Adv Hematol

March 2019

Department of Hematology and Oncology, West Cancer Clinic, 7945 Wolf River Blvd, Germantown, TN 38138, USA.

Article Synopsis
  • Brown recluse spider bites can cause serious health issues, including severe local reactions and systemic illnesses like hemolytic anemia and sepsis, potentially leading to hospitalization or even death.
  • A study reviewed nine patients with severe loxoscelism, revealing that most presented with symptoms such as fever, rash, and jaundice, and nearly half required intensive care due to complications like cellulitis and dermonecrosis.
  • While glucocorticoids were used for hemolytic anemia, they did not significantly affect recovery time but did reduce the need for blood transfusions, with all patients fully recovering within two weeks.
View Article and Find Full Text PDF

mHealth: Mobile Technologies to Virtually Bring the Patient Into an Oncology Practice.

Am Soc Clin Oncol Educ Book

December 2017

From the Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Department of Radiation Oncology, The Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL; Department of Radiation Oncology, University of Tennessee Health Sciences Center West Cancer Clinic; University of Tennessee Health Sciences Center, Vector Oncology, Memphis, TN.

Accompanied by the change in the traditional medical landscape, advances in wireless technology have led to the development of telehealth or mobile health (mHealth), which offers an unparalleled opportunity for health care providers to continually deliver high-quality care. This revolutionary shift makes the patient the consumer of health care and empowers patients to be the driving force of management of their own health through mobile devices and wearable technology. This article presents an overview of technology as it pertains to clinical practice considerations.

View Article and Find Full Text PDF

The purpose of this study was to describe direct and indirect costs associated with pain in cancer patients and to examine potential predictors of these costs. The study surveyed cancer outpatients about direct costs resulting from pain-related hospitalizations, emergency department visits, physician office visits, and use of analgesic medications and indirect costs related to money spent on pain-related transportation, complementary methods to improve pain management, educational materials, over-the counter medication, domestic support, and childcare. Furthermore, the study examined age, marital status, race, income level, pain severity, pain interference, and presence of breakthrough pain as predictors of direct and indirect costs.

View Article and Find Full Text PDF